This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization